Zili Hu

476 total citations
35 papers, 316 citations indexed

About

Zili Hu is a scholar working on Hepatology, Surgery and Oncology. According to data from OpenAlex, Zili Hu has authored 35 papers receiving a total of 316 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Hepatology, 16 papers in Surgery and 15 papers in Oncology. Recurrent topics in Zili Hu's work include Hepatocellular Carcinoma Treatment and Prognosis (18 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (13 papers) and Cancer Mechanisms and Therapy (5 papers). Zili Hu is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (18 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (13 papers) and Cancer Mechanisms and Therapy (5 papers). Zili Hu collaborates with scholars based in China, Sweden and Macao. Zili Hu's co-authors include Yaojun Zhang, Yizhen Fu, Zhongguo Zhou, Minshan Chen, Li Xu, Dandan Hu, Jinbin Chen, Juncheng Wang, Yangxun Pan and Chuan Liu and has published in prestigious journals such as Scientific Reports, Radiology and International Journal of Cancer.

In The Last Decade

Zili Hu

35 papers receiving 314 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zili Hu China 12 135 103 76 74 70 35 316
Vennis Lourdusamy United States 5 172 1.3× 102 1.0× 51 0.7× 58 0.8× 72 1.0× 16 320
Silvia Camera Italy 10 74 0.5× 164 1.6× 96 1.3× 71 1.0× 75 1.1× 27 388
Ziyu Xun China 11 112 0.8× 175 1.7× 72 0.9× 55 0.7× 114 1.6× 35 340
Ruocai Xu China 7 242 1.8× 131 1.3× 63 0.8× 71 1.0× 42 0.6× 11 349
Akinari Morinaga Japan 10 79 0.6× 108 1.0× 87 1.1× 123 1.7× 68 1.0× 25 312
Cheng‐Qian Zhong China 9 139 1.0× 47 0.5× 95 1.3× 77 1.0× 56 0.8× 20 277
Ting‐Jung Wu Taiwan 11 165 1.2× 94 0.9× 82 1.1× 64 0.9× 113 1.6× 21 359
Burcin Özdirik Germany 12 105 0.8× 112 1.1× 56 0.7× 41 0.6× 69 1.0× 24 319
Yanfu Sun China 10 144 1.1× 106 1.0× 87 1.1× 61 0.8× 152 2.2× 15 367

Countries citing papers authored by Zili Hu

Since Specialization
Citations

This map shows the geographic impact of Zili Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zili Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zili Hu more than expected).

Fields of papers citing papers by Zili Hu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zili Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zili Hu. The network helps show where Zili Hu may publish in the future.

Co-authorship network of co-authors of Zili Hu

This figure shows the co-authorship network connecting the top 25 collaborators of Zili Hu. A scholar is included among the top collaborators of Zili Hu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zili Hu. Zili Hu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Jinbin, Juncheng Wang, Yizhen Fu, et al.. (2025). Comparing PD‐L1 and PD‐1 inhibitors plus bevacizumab combined with hepatic arterial interventional therapies in unresetable hepatocellular carcinoma: A single‐center, real‐world study. International Journal of Cancer. 156(10). 1972–1985. 1 indexed citations
2.
Hu, Zili, Min Deng, Yizhen Fu, et al.. (2025). Neoadjuvant hepatic arterial infusion of oxaliplatin, fluorouracil, and leucovorin for resectable single large hepatocellular carcinoma. International Journal of Surgery. 111(6). 3850–3858. 2 indexed citations
3.
Zhang, Yaojun, Jinbin Chen, Zhongguo Zhou, et al.. (2025). Transarterial Chemoembolization with Radiofrequency Ablation versus Surgical Resection for Small Late-Recurrence Hepatocellular Carcinoma. Radiology. 314(2). e241096–e241096. 3 indexed citations
4.
Fu, Yizhen, Zili Hu, Yangxun Pan, et al.. (2024). Comparison of lenvatinib plus pembrolizumab versus first-line systemic chemotherapy for advanced intrahepatic cholangiocarcinoma: a real-world retrospective study. Frontiers in Immunology. 15. 1494520–1494520. 1 indexed citations
5.
Wang, Xin, Yizhen Fu, Weijie Wu, et al.. (2024). YTHDF2 in peritumoral hepatocytes mediates chemotherapy-induced antitumor immune responses through CX3CL1-mediated CD8+ T cell recruitment. Molecular Cancer. 23(1). 186–186. 17 indexed citations
6.
Yang, Yu, et al.. (2024). Patterns, Risk Factors, and Outcomes of Recurrence After Hepatectomy for Hepatocellular Carcinoma with and without Microvascular Invasion. Journal of Hepatocellular Carcinoma. Volume 11. 801–812. 9 indexed citations
7.
Hu, Zili, Weijie Wu, Zhongguo Zhou, et al.. (2023). Efficacy of additional locoregional therapy based on systemic therapy after intrahepatic progression for BCLC stage B/C hepatocellular carcinoma: A real-world study. International Immunopharmacology. 127. 111413–111413. 2 indexed citations
8.
9.
Li, Xinyuan, Xiang Zhou, Hang Tong, et al.. (2023). A Novel Hypoxia-related lncRNA Risk Score Model for Prognosis Evaluation of Clear Cell Renal Cell Carcinoma. Combinatorial Chemistry & High Throughput Screening. 28(15). 2589–2600. 1 indexed citations
10.
11.
Tang, Yuhao, Meiyan Zhu, Shuping Li, et al.. (2023). Size‐Tunable Nanoregulator‐Based Radiofrequency Ablation Suppresses MDSCs and Their Compensatory Immune Evasion in Hepatocellular Carcinoma. Advanced Healthcare Materials. 12(30). e2302013–e2302013. 15 indexed citations
12.
Fu, Yizhen, Zili Hu, Yangxun Pan, et al.. (2023). Levels of pretreatment serum lipids predict responses to PD-1 inhibitor treatment in advanced intrahepatic cholangiocarcinoma. International Immunopharmacology. 115. 109687–109687. 11 indexed citations
13.
14.
Fu, Yizhen, Zili Hu, Yangxun Pan, et al.. (2022). Inflammation-Based Scores Predict Responses to PD-1 Inhibitor Treatment in Intrahepatic Cholangiocarcinoma. Journal of Inflammation Research. Volume 15. 5721–5731. 20 indexed citations
15.
Hu, Zili, Yu Yuan, Qingbo Liu, et al.. (2022). Development and Validation of Prognostic Nomograms for Hepatocellular Carcinoma After Hepatectomy Based on Inflammatory Markers. Journal of Hepatocellular Carcinoma. Volume 9. 1403–1413. 2 indexed citations
16.
Hu, Zili, Juncheng Wang, Li Xu, et al.. (2022). Tenofovir vs. Entecavir on Outcomes of Hepatitis B Virus-Related Hepatocellular Carcinoma after Radiofrequency Ablation. Viruses. 14(4). 656–656. 10 indexed citations
17.
18.
Song, Fei, Chuan Liu, Junyong Zhang, & Zili Hu. (2020). Renal cell carcinoma with nephrotic syndrome: a case report and literature review. Translational Andrology and Urology. 9(3). 1459–1465. 10 indexed citations
19.
Song, Fei, et al.. (2019). Antibacterial effect of fosfomycin tromethamine on the bacteria inside urinary infection stones. International Urology and Nephrology. 52(4). 645–654. 7 indexed citations
20.
Hu, Zili. (2003). EXPERIMENTAL STUDY OF IMPACT LOCATION METHOD FOR PIEZOELECTRIC SMART STRUCTURE. Lixue yu shijian. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Vennis Lourdusamy Breakdown of academic impact, for papers by Silvia Camera Breakdown of academic impact, for papers by Ziyu Xun Breakdown of academic impact, for papers by Ruocai Xu Breakdown of academic impact, for papers by Akinari Morinaga Breakdown of academic impact, for papers by Cheng‐Qian Zhong Breakdown of academic impact, for papers by Ting‐Jung Wu Breakdown of academic impact, for papers by Burcin Özdirik Breakdown of academic impact, for papers by Yanfu Sun
Rankless by CCL
2026